Nifty

:

22570.35

Sensex

:

74339.44

167.95 (0.75%)
486.50 (0.66%)

Login

Nifty
Sensex

:
:

22570.35
74339.44

167.95 (0.75%)
486.50 (0.66%)

Panacea Biotec Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

42/99

BSE: 531349 | NSE: PANACEABIO

Watchlist

NSE BSE

146.50

25-Apr-2024

Open
High
Low
Previous Close

142.00
149.90
140.70
141.95

Volume
Traded Value (lacs)
52 Week High
52 Week Low

418127
612.84
202.50
114.20

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

894.57
N/A
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

767.36
N/A
1.06

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-1.03
0.14
-9.71

EBITDA CAGR (%)

10 Years
5 Years
3 Years

1.79
-5.95
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-11.41
-
-38.98

P:E (Median)

8 Years
5 Years
3 Years

-
0.60
0.57

P:BV (Average)

8 Years
5 Years
3 Years

-3.58
4.64
4.14

EV:EBITDA (Average)

8 Years
5 Years
3 Years

3.57
-5.52
-12.33

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 95.23 71.97 32.32% 94.59 48.74 94.07% 89.41 61.34 45.76% 75.02 41.50 80.77%
Expenses 88.59 59.68 48.44% 84.63 55.06 53.71% 82.60 133.36 -38.06% 71.59 60.88 17.59%
EBITDA 6.64 12.29 -45.97% 9.96 -6.32 - 6.81 -72.02 - 3.43 -19.38 -
EBIDTM 6.97% 17.08% 10.53% -12.97% 7.62% -117.41% 4.57% -46.70%
Other Income 3.05 9.71 -68.59% 2.13 7.92 -73.11% 3.34 6.53 -48.85% 10.27 2.57 299.61%
Interest 3.41 2.68 27.24% 3.55 2.21 60.63% 3.46 2.47 40.08% 2.70 1.44 87.50%
Depreciation 5.21 6.08 -14.31% 5.34 6.24 -14.42% 5.40 6.28 -14.01% 5.90 7.06 -16.43%
PBT 1.07 13.24 -91.92% 3.20 -6.85 - 1.29 -74.24 - 5.10 -25.31 -
Tax 0.64 0.00 0 0.00 0.00 0 0.00 0.00 0 24.79 0.00 0
PAT 0.43 13.24 -96.75% 3.20 -6.85 - 1.29 -74.24 - -19.69 -25.31 -
PATM 0.45% 18.40% 3.38% -14.05% 1.44% -121.03% -26.25% -60.99%
EPS 0.07 2.16 -96.76% 0.52 -1.12 - 0.21 -12.11 - -3.21 -4.13 -

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 150.50 115.20 30.64% 143.02 105.12 36.05% 129.19 110.70 16.70% 128.93 140.73 -8.38%
Expenses 150.65 123.84 21.65% 146.58 108.96 34.53% 139.50 190.51 -26.78% 134.60 170.92 -21.25%
EBITDA -0.15 -8.64 - -3.56 -3.84 - -10.31 -79.81 - -5.67 -30.19 -
EBIDTM -0.10% -7.50% -2.49% -3.65% -7.98% -72.10% -4.40% -21.45%
Other Income 5.68 13.94 -59.25% 3.23 10.45 -69.09% 6.08 12.21 -50.20% 15.06 4.05 271.85%
Interest 0.85 0.96 -11.46% 0.91 1.18 -22.88% 1.00 1.25 -20.00% 1.05 30.66 -96.58%
Depreciation 9.11 9.67 -5.79% 9.31 9.89 -5.86% 9.48 10.05 -5.67% 9.51 11.15 -14.71%
PBT -1.65 22.44 - -7.78 23.31 - 13.03 -51.16 - 18.21 1,608.26 -98.87%
Tax 0.55 3.07 -82.08% 0.51 7.61 -93.30% 2.05 4.98 -58.84% 30.89 370.79 -91.67%
PAT -2.20 19.37 - -8.29 15.70 - 10.98 -56.14 - -12.68 1,237.47 -
PATM -1.46% 16.81% -5.80% 14.94% 8.50% -50.71% -9.83% 879.32%
EPS -0.36 3.16 - -1.35 2.56 - 1.79 -9.16 - -2.07 201.87 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 354.25 257.07 235.50 343.56 489.68 444.16 574.19 530.09 646.90 679.20 497.57 Net Sales Growth 58.47% 9.16% -31.45% -29.84% 10.25% -22.65% 8.32% -18.06% -4.76% 36.50% Cost Of Goods Sold 145.57 163.06 112.09 176.26 150.72 179.70 197.00 168.83 214.35 288.60 208.08 Gross Profit 208.68 94.01 123.42 167.29 338.96 264.46 377.19 361.25 432.55 390.60 289.49 GP Margin 58.91% 36.57% 52.41% 48.69% 69.22% 59.54% 65.69% 68.15% 66.87% 57.51% 58.18% Total Expenditure 327.41 319.69 308.17 343.07 479.63 590.77 492.76 460.60 534.39 611.68 595.26 Power & Fuel Cost - 22.43 26.51 20.78 17.58 22.72 20.94 28.08 24.38 29.89 31.73 % Of Sales - 8.73% 11.26% 6.05% 3.59% 5.12% 3.65% 5.30% 3.77% 4.40% 6.38% Employee Cost - 71.03 72.50 59.47 123.24 141.94 136.74 132.21 139.80 133.23 142.73 % Of Sales - 27.63% 30.79% 17.31% 25.17% 31.96% 23.81% 24.94% 21.61% 19.62% 28.69% Manufacturing Exp. - 27.52 52.73 22.20 14.41 17.46 14.71 34.76 39.10 43.79 52.55 % Of Sales - 10.71% 22.39% 6.46% 2.94% 3.93% 2.56% 6.56% 6.04% 6.45% 10.56% General & Admin Exp. - 18.67 23.59 25.46 15.31 13.95 11.29 36.05 49.77 51.10 59.77 % Of Sales - 7.26% 10.02% 7.41% 3.13% 3.14% 1.97% 6.80% 7.69% 7.52% 12.01% Selling & Distn. Exp. - 12.81 9.26 28.18 10.00 4.09 5.66 36.74 43.79 44.14 46.03 % Of Sales - 4.98% 3.93% 8.20% 2.04% 0.92% 0.99% 6.93% 6.77% 6.50% 9.25% Miscellaneous Exp. - 4.17 11.50 10.71 148.38 210.91 106.42 23.93 23.20 20.93 46.03 % Of Sales - 1.62% 4.88% 3.12% 30.30% 47.49% 18.53% 4.51% 3.59% 3.08% 10.93% EBITDA 26.84 -62.62 -72.67 0.49 10.05 -146.61 81.43 69.49 112.51 67.52 -97.69 EBITDA Margin 7.58% -24.36% -30.86% 0.14% 2.05% -33.01% 14.18% 13.11% 17.39% 9.94% -19.63% Other Income 18.79 34.44 12.57 20.75 43.91 8.12 17.62 53.66 25.56 28.05 17.10 Interest 13.12 10.06 7.04 7.52 147.25 104.63 103.23 103.50 115.00 93.17 148.05 Depreciation 21.85 24.50 26.43 26.57 27.29 53.71 57.05 66.15 71.32 65.74 68.80 PBT 10.66 -62.75 -93.58 -12.85 -120.57 -296.83 -61.23 -46.50 -48.25 -63.34 -297.44 Tax 25.43 24.79 0.00 1.56 17.10 10.61 10.64 -11.38 0.53 1.89 0.00 Tax Rate 238.56% -39.51% 0.00% -12.14% -12.58% 28.54% -17.38% 13.54% 37.86% -2.98% 0.00% PAT -14.77 -87.54 -93.58 -14.41 -153.07 26.57 -71.88 -72.66 0.87 -65.23 -0.42 PAT before Minority Interest -14.77 -87.54 -93.58 -14.41 -153.07 26.57 -71.88 -72.66 0.87 -65.23 -0.42 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -4.17% -34.05% -39.74% -4.19% -31.26% 5.98% -12.52% -13.71% 0.13% -9.60% -0.08% PAT Growth 0.00% - - - - - - - - - EPS -2.41 -14.28 -15.27 -2.35 -24.97 4.33 -11.73 -11.85 0.14 -10.64 -0.07

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 551.64 459.95 661.23 624.80 544.06 456.70 592.79 544.01 653.08 687.19 509.99 Net Sales Growth 16.93% -30.44% 5.83% 14.84% 19.13% -22.96% 8.97% -16.70% -4.96% 34.75% Cost Of Goods Sold 237.85 252.66 262.20 204.63 156.79 172.24 187.25 149.52 215.81 280.21 214.00 Gross Profit 313.79 207.29 399.03 420.17 387.27 284.45 405.55 394.50 437.27 406.98 295.99 GP Margin 56.88% 45.07% 60.35% 67.25% 71.18% 62.28% 68.41% 72.52% 66.96% 59.22% 58.04% Total Expenditure 571.33 557.90 674.43 548.18 518.57 589.83 508.26 496.89 541.37 643.31 592.00 Power & Fuel Cost - 31.95 37.82 30.94 29.74 34.55 33.52 30.55 25.15 30.73 31.74 % Of Sales - 6.95% 5.72% 4.95% 5.47% 7.57% 5.65% 5.62% 3.85% 4.47% 6.22% Employee Cost - 126.48 182.97 156.17 144.42 147.08 151.59 148.12 142.02 135.98 144.92 % Of Sales - 27.50% 27.67% 25.00% 26.54% 32.20% 25.57% 27.23% 21.75% 19.79% 28.42% Manufacturing Exp. - 47.24 78.70 43.22 33.38 44.31 40.05 41.88 39.47 43.97 52.69 % Of Sales - 10.27% 11.90% 6.92% 6.14% 9.70% 6.76% 7.70% 6.04% 6.40% 10.33% General & Admin Exp. - 43.77 53.79 47.48 54.20 71.07 40.39 52.98 39.41 56.82 60.39 % Of Sales - 9.52% 8.13% 7.60% 9.96% 15.56% 6.81% 9.74% 6.03% 8.27% 11.84% Selling & Distn. Exp. - 42.70 48.08 51.18 42.81 31.27 36.98 37.70 44.20 44.20 46.09 % Of Sales - 9.28% 7.27% 8.19% 7.87% 6.85% 6.24% 6.93% 6.77% 6.43% 9.04% Miscellaneous Exp. - 13.10 10.86 14.56 57.24 89.31 18.48 36.14 35.31 51.40 46.09 % Of Sales - 2.85% 1.64% 2.33% 10.52% 19.56% 3.12% 6.64% 5.41% 7.48% 8.27% EBITDA -19.69 -97.95 -13.20 76.62 25.49 -133.13 84.53 47.12 111.71 43.88 -82.01 EBITDA Margin -3.57% -21.30% -2.00% 12.26% 4.69% -29.15% 14.26% 8.66% 17.11% 6.39% -16.08% Other Income 30.05 51.66 10.97 9.98 30.35 5.06 8.23 46.59 20.35 28.48 15.36 Interest 3.81 4.44 180.84 185.34 173.98 104.83 100.58 100.93 127.33 104.53 150.30 Depreciation 37.41 39.12 43.78 45.59 44.13 55.03 58.53 67.95 73.32 67.24 71.10 PBT 21.81 -89.86 -226.85 -144.32 -162.28 -287.93 -66.35 -75.17 -68.59 -99.41 -288.05 Tax 34.00 46.55 371.02 1.96 16.95 8.56 9.86 -10.98 1.92 3.08 1.68 Tax Rate 155.89% 363.67% 25.60% -1.36% -9.54% 18.58% -14.86% 16.28% -10.14% -3.10% -1.51% PAT -12.19 -33.23 1,078.31 -146.24 -194.60 37.58 -74.18 -54.75 -18.51 -100.70 -111.56 PAT before Minority Interest -12.19 -33.74 1,078.33 -146.20 -194.63 37.52 -76.20 -56.47 -20.85 -102.49 -112.64 Minority Interest 0.00 0.51 -0.02 -0.04 0.03 0.06 2.02 1.72 2.34 1.79 1.08 PAT Margin -2.21% -7.22% 163.08% -23.41% -35.77% 8.23% -12.51% -10.06% -2.83% -14.65% -21.87% PAT Growth -101.00% - - - - - - - - - EPS -1.99 -5.42 175.91 -23.86 -31.75 6.13 -12.10 -8.93 -3.02 -16.43 -18.20

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 325.65 415.09 508.17 892.73 418.47 388.10 455.82 540.03 539.71 562.29 Share Capital 6.13 6.13 6.13 6.13 6.13 6.13 6.13 22.43 22.43 6.13 Total Reserves 319.53 408.97 502.04 854.61 412.35 381.97 449.69 517.60 517.28 556.16 Non-Current Liabilities 316.77 271.46 254.07 247.15 253.46 748.33 874.35 963.59 809.56 662.22 Secured Loans 0.18 0.24 2.05 6.35 8.90 561.25 704.57 777.88 627.24 478.72 Unsecured Loans 102.22 83.87 60.03 54.08 79.41 9.46 9.49 1.00 1.20 1.40 Long Term Provisions 184.17 184.77 183.84 182.75 183.68 195.31 187.39 184.37 180.42 180.37 Current Liabilities 250.85 244.16 199.52 167.35 921.09 685.27 589.90 474.00 698.70 830.69 Trade Payables 129.12 144.94 124.06 135.90 77.88 241.84 226.75 173.50 186.97 226.26 Other Current Liabilities 92.99 70.35 71.02 24.79 764.16 242.81 142.05 80.88 186.75 248.12 Short Term Borrowings 0.00 0.00 0.00 3.57 69.39 193.82 219.65 218.25 319.83 354.41 Short Term Provisions 28.74 28.86 4.44 3.10 9.66 6.79 1.45 1.37 5.15 1.90 Total Liabilities 893.27 930.71 961.76 1,307.23 1,593.02 1,821.70 1,920.07 1,977.62 2,047.97 2,055.20 Net Block 385.31 416.13 398.44 447.29 496.44 890.93 942.01 987.58 1,059.68 1,085.95 Gross Block 852.15 865.20 826.40 863.64 1,087.87 1,542.55 1,536.97 1,518.16 1,532.12 1,493.54 Accumulated Depreciation 466.84 449.07 427.96 416.36 591.43 651.62 594.95 530.58 472.44 407.59 Non Current Assets 690.25 644.49 669.21 692.91 676.91 1,468.04 1,510.70 1,636.51 1,732.80 1,764.09 Capital Work in Progress 27.85 0.88 12.97 3.74 3.10 37.16 27.68 19.01 16.98 26.08 Non Current Investment 0.27 0.27 0.27 54.53 2.54 344.88 344.88 394.66 394.66 394.20 Long Term Loans & Adv. 225.33 188.82 187.45 186.50 173.95 194.69 195.57 234.01 260.43 257.68 Other Non Current Assets 1.44 0.49 4.27 0.85 0.89 0.39 0.55 1.25 1.05 0.18 Current Assets 199.13 248.83 292.55 614.32 916.11 353.65 409.37 341.11 315.17 291.11 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 116.10 129.25 87.04 99.23 42.51 149.09 140.60 136.57 140.90 176.76 Sundry Debtors 12.27 23.32 35.29 17.69 25.20 142.27 175.80 142.21 100.43 90.58 Cash & Bank 43.25 42.69 88.96 60.61 7.85 11.79 7.21 9.32 42.37 9.68 Other Current Assets 27.51 2.40 44.36 409.85 840.56 50.50 85.75 53.01 31.47 14.09 Short Term Loans & Adv. 25.28 51.17 36.90 26.95 31.20 40.95 72.01 44.39 23.73 6.05 Net Current Assets -51.72 4.67 93.03 446.97 -4.98 -331.62 -180.53 -132.89 -383.53 -539.58 Total Assets 889.38 893.32 961.76 1,307.23 1,593.02 1,821.69 1,920.07 1,977.62 2,047.97 2,055.20

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 843.60 876.64 -228.69 198.79 350.40 308.68 355.68 448.61 471.29 512.72 Share Capital 6.13 6.13 6.13 6.13 6.13 6.13 6.13 22.43 22.43 6.13 Total Reserves 837.48 870.51 -234.82 160.66 344.27 302.55 349.55 426.18 448.76 506.59 Non-Current Liabilities 99.22 85.10 959.99 740.66 70.08 591.13 718.78 1,100.11 918.47 767.07 Secured Loans 0.18 0.24 675.05 583.55 8.90 560.45 704.57 866.08 721.77 581.77 Unsecured Loans 19.98 33.87 60.03 29.58 37.22 10.26 9.49 1.00 1.20 1.40 Long Term Provisions 26.55 29.16 30.65 42.74 39.78 26.54 18.36 184.42 180.43 180.47 Current Liabilities 329.73 773.77 449.09 622.14 938.26 695.52 689.13 474.80 706.03 826.82 Trade Payables 177.32 234.72 246.66 198.85 269.71 277.19 248.60 187.87 209.13 252.11 Other Current Liabilities 115.71 503.01 189.06 242.12 585.25 242.00 237.52 93.60 194.85 251.91 Short Term Borrowings 0.00 0.00 0.00 3.57 69.39 164.88 190.71 191.82 295.84 320.67 Short Term Provisions 36.70 36.03 13.37 177.60 13.92 11.44 12.30 1.51 6.21 2.13 Total Liabilities 1,269.06 1,732.53 1,177.39 1,558.55 1,355.73 1,592.38 1,774.13 2,024.60 2,099.21 2,112.09 Net Block 599.95 622.07 608.70 657.39 805.56 948.97 1,001.37 1,071.11 1,144.30 1,275.54 Gross Block 1,330.83 1,313.94 1,266.39 1,282.22 1,392.90 1,605.84 1,600.07 1,620.29 1,633.48 1,697.63 Accumulated Depreciation 730.88 691.87 657.69 624.84 587.34 656.87 598.70 549.18 489.18 422.09 Non Current Assets 702.85 744.57 666.41 875.27 847.84 1,027.55 1,070.91 1,475.22 1,573.49 1,739.28 Capital Work in Progress 42.32 17.26 34.42 24.01 22.51 39.92 30.41 115.78 110.31 116.55 Non Current Investment 0.07 0.07 0.07 5.58 5.33 5.25 7.01 5.19 10.20 15.97 Long Term Loans & Adv. 56.76 21.46 17.62 187.70 13.33 28.01 22.03 236.71 262.44 274.94 Other Non Current Assets 3.74 83.71 5.61 0.60 1.12 5.39 10.09 1.26 1.07 0.35 Current Assets 562.32 950.55 510.97 683.27 507.89 564.83 703.22 549.38 525.72 372.81 Current Investments 13.42 5.00 0.00 0.00 0.00 2.03 0.27 3.52 4.98 0.00 Inventories 202.09 212.72 174.14 147.69 81.43 334.21 315.55 305.24 310.22 219.81 Sundry Debtors 60.09 81.66 84.68 68.52 88.73 136.01 142.17 141.67 98.57 94.93 Cash & Bank 225.99 583.28 135.79 89.75 23.48 23.24 14.13 22.93 52.40 24.78 Other Current Assets 60.72 8.75 52.64 335.69 314.25 69.36 231.09 76.02 59.55 33.29 Short Term Loans & Adv. 52.31 59.15 63.72 41.62 41.02 59.30 56.21 66.76 50.15 24.72 Net Current Assets 232.59 176.79 61.88 61.13 -430.38 -130.69 14.08 74.58 -180.31 -454.01 Total Assets 1,265.17 1,695.12 1,177.38 1,558.54 1,355.73 1,592.38 1,774.13 2,024.60 2,099.21 2,112.09

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity -10.74 -52.69 38.27 -82.86 107.16 172.06 103.83 97.85 44.75 53.17 PBT -62.75 -93.58 -12.88 -135.97 37.18 -61.23 -84.04 1.40 -63.34 -0.42 Adjustment 10.43 35.98 31.82 204.95 -67.89 160.40 184.07 133.41 141.57 -53.14 Changes in Working Capital 42.67 5.73 20.30 -143.93 137.45 73.35 -2.52 -57.72 -30.18 108.02 Cash after chg. in Working capital -9.66 -51.87 39.24 -74.96 106.74 172.51 97.51 77.09 48.05 54.46 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.09 -0.82 -0.98 -7.90 0.42 -0.45 6.32 20.76 -3.30 -1.29 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 2.41 39.54 -37.32 -18.52 -8.33 -2.73 -17.92 22.74 -29.24 -18.30 Net Fixed Assets -13.92 -26.71 28.01 223.59 488.74 -15.06 -27.48 11.93 -29.48 -5.26 Net Investments 0.00 0.00 54.26 -51.99 342.34 0.00 49.78 0.00 -0.46 -122.35 Others 16.33 66.25 -119.59 -190.12 -839.41 12.33 -40.22 10.81 0.70 109.31 Cash from Financing Activity 9.01 9.83 -7.20 109.39 -98.45 -163.67 -91.06 -128.69 -10.88 -37.78 Net Cash Inflow / Outflow 0.67 -3.32 -6.26 8.02 0.37 5.66 -5.15 -8.10 4.63 -2.91 Opening Cash & Equivalents 5.33 8.66 14.91 4.96 6.52 0.86 6.01 14.13 9.50 12.39 Closing Cash & Equivalent 6.01 5.33 8.66 14.91 4.96 6.52 0.86 6.04 14.13 9.50

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity -422.45 -108.45 106.76 -30.47 104.80 118.02 130.67 90.69 37.23 53.73 PBT 12.81 1,449.36 -145.03 -177.34 46.23 -66.14 -67.18 -18.93 -99.41 -110.96 Adjustment -95.87 -1,454.97 230.88 253.04 -70.58 166.62 149.57 148.75 167.45 59.92 Changes in Working Capital -336.91 300.86 21.91 -97.50 127.32 21.45 43.32 -58.26 -25.16 107.22 Cash after chg. in Working capital -419.98 295.25 107.76 -21.80 102.97 121.93 125.71 71.56 42.88 56.18 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.48 -403.70 -1.00 -8.67 1.83 -3.91 4.96 19.13 -5.65 -2.45 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 430.33 1,282.57 -47.68 -34.76 -5.27 55.29 -25.83 16.44 -37.38 -37.60 Net Fixed Assets -13.92 -26.71 28.01 223.59 488.74 -15.06 -27.48 11.93 -29.48 -5.26 Net Investments 0.00 0.00 54.26 -51.99 342.34 0.00 49.78 0.00 -0.46 -122.35 Others 444.25 1,309.28 -129.95 -206.36 -836.35 70.35 -48.13 4.51 -7.44 90.01 Cash from Financing Activity -18.37 -1,175.84 -47.11 90.74 -101.14 -164.35 -106.96 -117.38 -0.70 -30.26 Net Cash Inflow / Outflow -10.49 -1.72 11.97 25.51 -1.61 8.97 -2.13 -10.25 -0.85 -14.13 Opening Cash & Equivalents 50.35 52.08 40.22 14.47 16.44 7.47 9.59 19.97 20.84 34.95 Closing Cash & Equivalent 39.85 50.35 52.08 40.22 14.47 16.44 7.47 9.73 19.99 20.84

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 53.17 67.77 82.97 140.53 68.32 63.36 74.42 18.54 18.49 29.22 ROA -9.57% -9.88% -1.27% -10.56% 1.56% -3.84% -3.73% 0.04% -3.18% -0.02% ROE -23.64% -20.27% -2.11% -23.93% 6.59% -17.03% -25.52% 0.77% -44.62% -0.23% ROCE -11.36% -16.14% -0.70% 1.09% 11.51% 2.96% 1.48% 10.15% 2.58% 12.95% Fixed Asset Turnover 0.30 0.28 0.41 0.50 0.34 0.38 0.36 0.42 0.45 0.33 Receivable days 25.11 45.26 27.77 15.98 68.81 100.51 106.68 68.41 51.29 58.36 Inventory Days 173.06 167.03 97.64 52.82 78.73 91.54 92.98 78.23 85.30 147.07 Payable days 306.74 437.99 269.16 104.62 146.14 199.79 153.09 120.20 124.84 135.12 Cash Conversion Cycle -108.57 -225.70 -143.75 -35.82 1.40 -7.74 46.57 26.45 11.76 70.31 Total Debt/Equity 0.31 0.20 0.13 0.08 1.65 2.50 2.24 7.84 7.83 5.53 Interest Cover -5.24 -12.29 -0.71 0.08 1.36 0.41 0.19 1.01 0.32 1.00

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 137.73 143.12 -37.34 27.23 57.21 50.40 58.07 -4.43 -0.75 13.96 ROA -2.24% 74.05% -10.69% -13.36% 2.55% -4.53% -2.97% -1.01% -4.87% -5.47% ROE -3.92% 332.85% 0.00% -75.26% 11.39% -22.94% -34.38% 0.00% -253.03% -76.49% ROCE 1.94% 217.12% 5.36% -0.38% 13.44% 2.63% 2.76% 9.93% 0.45% 3.37% Fixed Asset Turnover 0.36 0.54 0.51 0.41 0.30 0.37 0.35 0.40 0.41 0.30 Receivable days 54.62 43.66 42.68 52.75 89.81 85.16 92.84 67.10 51.36 58.89 Inventory Days 159.84 101.55 89.66 76.86 166.09 198.91 203.06 171.89 140.68 174.32 Payable days 297.63 335.05 397.33 178.20 213.56 186.55 163.89 130.73 137.37 148.94 Cash Conversion Cycle -83.17 -189.84 -264.98 -48.60 42.34 97.52 132.00 108.26 54.67 84.27 Total Debt/Equity 0.02 0.04 -3.58 4.45 1.85 3.05 2.79 -100.22 93.42 12.38 Interest Cover 3.89 9.01 0.22 -0.02 1.44 0.34 0.33 0.85 0.05 0.26

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Panacea Biotec - Quarterly Results
13th Feb 2024, 14:50 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback